Connect your AI

BBNX BBNX Change in Deferred Revenue

Change in Deferred Revenue at other companies

Tandem Diabetes CareTNDM

-$1.08M+32.5%

Other financials

Income statement

Revenue$27.6M+56.6%

Gross profit$16.4M+83.2%

Operating income-$24.3M-30.2%

Net income-$21.9M+23.6%

EPS (diluted)-$0.49+47.3%

Balance sheet

Cash & equivalents$30.2M-28.9%

Total debt$6.9M-0.9%

Total equity$271.2M-13.5%

Total assets$304.4M-9.9%

Cash flow

Operating cash flow-$23.8M-19.3%

CapEx$1.4M+314%

Free cash flow-$25.2M-24.1%

Valuation

Market cap$708.98M-8.6%

Enterprise value$685.68M—

P/S6.4×—

Profitability

Gross margin57.2%+3.2pp

Operating margin-70.1%-6.4pp

Net margin-60.3%-17.4pp

FCF margin-55.4%-14.3pp

Returns & leverage

Return on equity-22.7%—

Debt / equity0×0.0×

Current ratio10.7×-5.2×

Where this comes from

Reported directly by BBNX in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInDeferredRevenue.

The official record: BBNX’s 10-Q, filed April 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about BBNX's change in deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is BBNX's change in deferred revenue?: BBNX (BBNX) reported change in deferred revenue of $201K in Q1 2026.
How has BBNX's change in deferred revenue changed year-over-year?: BBNX's change in deferred revenue decreased by 58.1% year-over-year, from $480K to $201K.
What is the long-term trend for BBNX's change in deferred revenue?: Over 2 years (2023 to 2025), BBNX's change in deferred revenue has grown at a 145.1% compound annual growth rate (CAGR), from $342K to $2.06M.
What does change in deferred revenue mean?: Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.